← SynDRA
GSK650394
SynDRA canonical compound SYN1970477 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SGK1 | SGK2 |
|---|
| Mechanism of action | serum/glucocorticoid regulated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- serum/glucocorticoid regulated kinase inhibitor
Cross-references
Synonyms
- GSK-650394
- 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
- CHEMBL558642
- 56887611DJ
- 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid
- Benzoic acid, 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-
- 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid.
- UNII-56887611DJ
- DXV
- MLS006010262
- GTPL8040
- SCHEMBL3767908
- CHEBI:95066
- DTXSID60237532
- HMS2043A20
- HMS3413P22
- HMS3653A19
- HMS3677P22
- HMS3743K03
- BCP08392
- EX-A2233
- BDBM50296011
- MFCD12828779
- s7209
- ZINC43015507
- AKOS024457693
- CCG-265020
- CS-1853
- NCGC00250410-01
- NCGC00250410-12
- NCGC00250410-15
- AC-32637
- AS-16796
- DA-01459
- HY-15192
- SMR004701335
- FT-0742103
- SW219479-1
- J3.540.996C
Look up GSK650394 in the interactive SynDRA portal →